Fingerprint
Dive into the research topics of 'Phase 1 study of tipifarnib in combination with imatinib for patients with chronic myelogenous leukemia in chronic phase after imatinib failure'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically